Description
While NAD+ pathway emerged as top therapeutic target with strong clinical validation, the debate lacked mechanistic understanding of APOE4-specific NAD+ metabolism disruptions. This knowledge gap limits optimal dosing and timing strategies for clinical translation.
Source: Debate session sess_SDA-2026-04-08-gap-debate-20260406-062033-fecb8755 (Analysis: SDA-2026-04-08-gap-debate-20260406-062033-fecb8755)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:53.204081+00:00”, “resolution_summary”: “Resolved by hypothesis h-42f50a4a: Prime Editing Precision Correction of APOE4 to APOE3 in Microglia. Supporting evidence includes debate sess_AD-MASTER-PLAN-APOE-20260428030754_task_66f1207e_ctx.”, “match_counts”: {“hypothesis_matches”: 5, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-42f50a4a”, “title”: “Prime Editing Precision Correction of APOE4 to APOE3 in Microglia”, “score”: 0.364, “reason”: “20 token overlaps; entity overlap: apoe3, apoe4”, “analysis_id”: “SDA-2026-04-03-gap-crispr-neurodegeneration-20260402”, “target_gene”: “APOE”, “target_pathway”: “APOE-mediated cholesterol/lipid transport”, “disease”: “neurodegeneration”, “composite_score”: 0.826767, “confidence_score”: 0.7, “status”: “promoted”, “pubmed_evidence_ids”: [“39642875”, “40639927”, “41276911”, “41288387”, “41338186”]}, {“id”: “h-9dc6fc2bb1”, “title”: “APOE4-Targeted Microglial Reprogramming via Anti-APOE4 Antibodies”, “score”: 0.361, “reason”: “5 token overlaps; entity overlap: apoe4, apoe4-”, “analysis_id”: “test-hypothesis-fixtures-v1”, “target_gene”: “APOE”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.67, “confidence_score”: 0.8, “status”: “proposed”, “pubmed_evidence_ids”: [“26952885”, “29674595”, “33831375”]}, {“id”: “h-var-600b3e39aa”, “title”: “APOE4-Specific Proteolytic Fragment Inhibition Therapy”, “score”: 0.359, “reason”: “23 token overlaps; entity overlap: apoe4, apoe4-”, “analysis_id”: null, “target_gene”: “APOE”, “target_pathway”: “APOE4 proteolytic cleavage pathway”, “disease”: “Alzheimer’s disease”, “composite_score”: 0.777, “confidence_score”: 0.65, “status”: “proposed”, “pubmed_evidence_ids”: [“28959956”, “31367008”, “31564456”, “32209402”, “32726626”]}, {“id”: “h-var-fd2fd0825b”, “title”: “APOE4-Targeted Ultrasonic Lipidation Enhancement for Gamma Oscillation Restoration in Alzheimer’s Disease”, “score”: 0.339, “reason”: “15 token overlaps; entity overlap: apoe4, apoe4-”, “analysis_id”: null, “target_gene”: “APOE/PVALB”, “target_pathway”: “APOE4 lipidation enhancement → PV interneuron metabolic support → gamma oscillation restoration”, “disease”: “Alzheimer’s disease”, “composite_score”: 0.625, “confidence_score”: 0.41, “status”: “proposed”, “pubmed_evidence_ids”: [“28959956”, “31367008”, “31564456”, “32209402”, “32726626”]}, {“id”: “h-6ae3f31128”, “title”: “H6: Epigenetic Reset via APOE4→APOE3 Conversion Reverses Senescence”, “score”: 0.332, “reason”: “11 token overlaps; entity overlap: apoe3, apoe4”, “analysis_id”: “SDA-2026-04-06-gap-debate-20260406-062101-5d7b9dc0”, “target_gene”: “APOE; HDAC1; EZH2”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.54, “confidence_score”: 0.45, “status”: “proposed”, “pubmed_evidence_ids”: [“24553505”, “29991820”, “30617341”]}], “debate_matches”: [{“id”: “sess_AD-MASTER-PLAN-APOE-20260428030754_task_66f1207e_ctx”, “title”: “APOE4-driven lipid dysregulation and synaptic phagocytosis drive AD; converting APOE4 to APOE3 reduces amyloid and restores synaptic function”, “score”: 0.496, “reason”: “3 token overlaps; entity overlap: apoe3, apoe4, apoe4-”, “analysis_id”: “AD-MASTER-PLAN-APOE-20260428030754”, “quality_score”: 0.641, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-10-gap-debate-20260410-075026-23501c3c_task_9aae8fc5”, “title”: “The debate identified this as the core knowledge gap but provided no mechanistic insights. Understanding these selectivity rules is essential for predicting which proteins will aberrantly phase separate in disease and for designing therapeutic interventions.\n\nSource: Debate session sess_SDA-2026-04-08-gap-pubmed-20260406-062229-3ab00c95 (Analysis: SDA-2026-04-08-gap-pubmed-20260406-062229-3ab00c95)”, “score”: 0.424, “reason”: “9 token overlaps; entity overlap: sda-2026-04-08-”, “analysis_id”: “SDA-2026-04-10-gap-debate-20260410-075026-23501c3c”, “quality_score”: 0.713, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-09-gap-debate-20260409-201742-1e8eb3bd_20260412-091505”, “title”: “The debate mentioned tau PTM targeting but did not identify which modifications are both disease-specific and accessible for therapeutic intervention. This knowledge gap limits the development of PTM-based selective targeting approaches.\n\nSource: Debate session sess_SDA-2026-04-08-gap-debate-20260406-062052-81a54bfd (Analysis: SDA-2026-04-08-gap-debate-20260406-062052-81a54bfd)”, “score”: 0.402, “reason”: “8 token overlaps; entity overlap: sda-2026-04-08-”, “analysis_id”: “SDA-2026-04-09-gap-debate-20260409-201742-1e8eb3bd”, “quality_score”: 0.84, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-09-gap-debate-20260409-201742-1e8eb3bd_20260412-091129”, “title”: “The debate mentioned tau PTM targeting but did not identify which modifications are both disease-specific and accessible for therapeutic intervention. This knowledge gap limits the development of PTM-based selective targeting approaches.\n\nSource: Debate session sess_SDA-2026-04-08-gap-debate-20260406-062052-81a54bfd (Analysis: SDA-2026-04-08-gap-debate-20260406-062052-81a54bfd)”, “score”: 0.402, “reason”: “8 token overlaps; entity overlap: sda-2026-04-08-”, “analysis_id”: “SDA-2026-04-09-gap-debate-20260409-201742-1e8eb3bd”, “quality_score”: 0.71, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-12-gap-debate-20260410-112837-d8c6fc48”, “title”: “The debate revealed that no high-resolution structure exists for the critical hinge region (residues 130-160) that allegedly mediates APOE4’s pathological conformation. This structural knowledge gap prevents rational design of allosteric modulators and limits understanding of the molecular basis for APOE4’s dysfunction.\n\nSource: Debate session sess_SDA-2026-04-01-gap-010 (Analysis: SDA-2026-04-01-gap-010)”, “score”: 0.359, “reason”: “8 token overlaps; entity overlap: apoe4”, “analysis_id”: “SDA-2026-04-12-gap-debate-20260410-112837-d8c6fc48”, “quality_score”: 0.5, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}